PURPOSE To provide recommendations for appropriate dosing of systemic antineoplastic
agents in obese adults with cancer. METHODS A systematic review of the literature collected …

Background Acute myeloid leukaemia (AML) is treated with intensive induction
chemotherapy (IT) in medically fit patients. In general, obesity was identified as a risk factor …

Previous studies have demonstrated an association between high body mass index (BMI)
and acute myeloid leukemias (AML), particularly acute promyelocytic leukemia (APL) …

Introduction: Obesity is a major risk factor for chronic disease and cancer development.
Therapeutic management of obese patients with cancer is a real challenge for physician …

We assessed the influence of obesity on the characteristics and prognosis of acute myeloid
leukemia (AML). Indeed, safety of intensive chemotherapy and outcome of obese AML …

Overweight and obese patients have an increased risk to develop several malignancies
and, additionally, body mass index (BMI) impacts on outcome in several solid tumors …

Lung cancer, especially non-small cell lung cancer (NSCLC), represents enormous
challenges in continuously achieving treatment improvements. Besides cancer, obesity is …

Recent studies have described various impacts of obesity and being overweight on acute
myeloid leukemia (AML) outcomes in adult patients, but little is known about the impact of …

Overweight patients with cancer are frequently reduced in chemotherapy dose due to toxicity
concerns, although previous studies have indicated that dose reduction (DR) of overweight …

Objectives Anthracyclines and cytarabine are cornerstones for intensive chemotherapy in
acute myeloid leukemia (AML). The goals of this study were to comprehensively assess …